An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators

Linette R. Klevan, RN;Martha M. Tenzer, BA;Robert C. Bernstein, MD;John M. Herre, MD;

Publication

Article

September 1, 1995

The American Journal of Managed Care

September 1995

Volume1

Issue 1

An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators

Author(s):

Linette R. Klevan, RN,Martha M. Tenzer, BA

Download PDF: An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators

Articles in this issue

ETO TITLE

The Cost of Treatment of Endometriosis in the California Medicaid Population

An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators

Effects of Nurse Specialist Transitional Care on Patient Outcomes and Cost: Results of Five Randomized Trials

Declining Resource Utilization in Interventional Cardiology?

Urinary Incontinence: An Overview of the Diagnosis and Management

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators

Newsletter